T- XELOX in HER2-positive Stage III Gastric Cancer After D2 Gastrectomy

NCT02250209 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Gastric Cancer

Interventions

DRUG: Trastuzumab
DRUG: Capecitabine
DRUG: Oxaliplatin

Sponsor

Chinese PLA General Hospital